NCT04484714: MY-PROGRESS

Virtual Exercise for Multiple Myeloma

Completed NA Last updated 17 September 2021

What this trial tests

NA trial testing Exercise in Multiple Myeloma in 31 participants. Completed in 31 August 2021.

Timeline

15 September 2020

Primary endpoint
15 June 2021

31 August 2021

Quick facts

Lead sponsor	University of Alberta
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	31
Start date	15 September 2020
Primary completion	15 June 2021
Estimated completion	31 August 2021
Sites	1 location across Canada

Drugs / interventions tested

• Exercise

Conditions studied

• Multiple Myeloma — all drugs for Multiple Myeloma →

Sponsor

University of Alberta

Who can join

18 and older, any sex, with Multiple Myeloma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this pilot study is to determine the safety and feasibility a 12-week virtually supported home-based aerobic and resistance exercise program progressing cancer survivors with Multiple Myeloma to meet standards identified in the 2019 Exercise Guidelines for Cancer Survivors.

The protocol will be measuring recruitment, adherence, completion, cost tracking, as well as fitness and quality of life outcomes. The study will be a single-group prospective before and after study that will help inform a future larger-scale project. We will aim to recruit 25 participants.

The Health Research Ethics Board of Alberta Cancer Committee will approve this study. Participants will participate in a combined resistance and aerobic exercise program biweekly for 12 weeks. Exercise sessions will be supported and progressive in nature, between 40 and 75 minutes each.

Analyses: fitness testing and quality of life scales will be administered before and after the intervention. Scores will be compared to evaluate changes over the course of the intervention. Safety and feasibility information will be collected throughout the study and evaluated to determine program feasibility. Program satisfaction will be evaluated using a satisfaction survey.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

1. Feasibility of a tailored and virtually supported home exercise program for people with multiple myeloma using a novel eHealth application.
   Purdy GM, Venner CP, Tandon P, McNeely ML. · · 2022 · cited 15× · PMID 36249481 · DOI 10.1177/20552076221129066
2. Exploring participant perceptions of a virtually supported home exercise program for people with multiple myeloma using a novel eHealth application: a qualitative study.
   Purdy GM, Sobierajski FM, Al Onazi MM, Effa CJ, et al · · 2023 · cited 3× · PMID 37097319 · DOI 10.1007/s00520-023-07762-y
3. Exercise and Diet Studies Among Patients Living with Multiple Myeloma: Current Evidence and Considerations of Patient Preferences.
   Maslana KE, Skogerboe GE, Sborov DW, Coletta AM. · · 2025 · PMID 40970124 · DOI 10.3389/frhem.2025.1550681